Free Trial

Krystal Biotech (KRYS) SEC Filings & 10K Form

Krystal Biotech logo
$178.10 +0.25 (+0.14%)
(As of 11/20/2024 ET)

Recent Krystal Biotech SEC Filings

DateFilerForm TypeView
11/14/2024
8:00 PM
Krystal Biotech (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/04/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:05 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2024
11:28 AM
Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/13/2024
4:41 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:44 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:45 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:33 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:33 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:31 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:03 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:08 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
12:14 PM
Krystal Biotech (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
07/01/2024
6:32 PM
Krystal Biotech (Issuer)
Mason Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:34 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:37 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:21 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:24 PM
Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:29 PM
Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:31 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:33 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:17 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:38 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
3:51 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
7:17 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/04/2024
3:08 PM
Krystal Biotech (Filer)
Form DEF 14A
04/04/2024
3:09 PM
Krystal Biotech (Filer)
Form DEFA14A
03/11/2024
7:24 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:27 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:36 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:37 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
7:20 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:09 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:13 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:16 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:39 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:33 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:36 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
12:35 PM
Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
02/26/2024
6:59 AM
Krystal Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:49 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
8:25 AM
Avoro Capital Advisors LLC (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
01/29/2024
2:26 PM
Krystal Biotech (Subject)
Form SC 13G/A
01/24/2024
4:44 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
10:43 AM
Krystal Biotech (Subject)
Romano Kathryn (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:17 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:19 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
3:20 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KRYS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners